We use cookies to improve the function of this site and enhance the user experience.
Learn more about our cookie policy and how to modify your cookie settings.
UK/CORP/15-0012l. Date of preparation: July 2015
United Kingdom
Search    
Include All CSL Behring Country Sites

Pharmacovigilance & Traceability

CSL Behring products are continuously monitored for safety and efficacy through our extensive quality and safety systems, especially pharmacovigilance (post-marketing monitoring for possible adverse reactions) and traceability. These systems provide an additional level of oversight by tracking and monitoring any potential adverse events of manufactured products.

Pharmacovigilance is an important tool to monitor the safety of a product and detect adverse reactions. Traceability ensures that we can not only readily trace our manufactured products to a patient, but also trace our products from patient to a specific batch of products. Adverse events will be investigated, evaluated and reported to appropriate regulatory bodies.

To report an adverse event please contact Medical Information on 01444 447 405, send an email or go to www.mhra.gov.uk/yellowcard.

UK/CORP/15-0012b Date of preparation: July 2015